Abha Sahni
Hematology/Oncology Division
Department of Medicine
University of Rochester School of Medicine and Dentistry
Rochester
USA
Name/email consistency: high
- Fibrinogen synthesized by cancer cells augments the proliferative effect of fibroblast growth factor-2 (FGF-2). Sahni, A., Simpson-Haidaris, P.J., Sahni, S.K., Vaday, G.G., Francis, C.W. J. Thromb. Haemost. (2008)
- FGF-2 binding to fibrin(ogen) is required for augmented angiogenesis. Sahni, A., Khorana, A.A., Baggs, R.B., Peng, H., Francis, C.W. Blood (2006)
- Endothelial cell activation by IL-1beta in the presence of fibrinogen requires alphavbeta3. Sahni, A., Sahni, S.K., Francis, C.W. Arterioscler. Thromb. Vasc. Biol. (2005)
- Interleukin-1beta but not IL-1alpha binds to fibrinogen and fibrin and has enhanced activity in the bound form. Sahni, A., Guo, M., Sahni, S.K., Francis, C.W. Blood (2004)
- Stimulation of endothelial cell proliferation by FGF-2 in the presence of fibrinogen requires alphavbeta3. Sahni, A., Francis, C.W. Blood (2004)
- Fibrinogen binding potentiates FGF-2 but not VEGF induced expression of u-PA, u-PAR, and PAI-1 in endothelial cells. Sahni, A., Sahni, S.K., Simpson-Haidaris, P.J., Francis, C.W. J. Thromb. Haemost. (2004)
- Plasmic degradation modulates activity of fibrinogen-bound fibroblast growth factor-2. Sahni, A., Francis, C.W. J. Thromb. Haemost. (2003)
- FGF-2 but not FGF-1 binds fibrin and supports prolonged endothelial cell growth. Sahni, A., Altland, O.D., Francis, C.W. J. Thromb. Haemost. (2003)